aTyr Pharma (ATYR) Financials: Revenue & Earnings
ATYR$0.13+0.00 +2.42%
$12.46M
Market Cap
-0.25
P/E
0.44
Forward P/E
62
Score
aTyr Pharma (ATYR) Financials: Revenue & Earnings
ATYR price $0.13 +0.00 +2.42%
- Ticker
- ATYR
- Price
- $0.13
- Change
- +0.00 +2.42%
- Market cap ?
- $12.46M
- P/E ?
- -0.25
- Forward P/E ?
- 0.44
- Dividend yield ?
- 0.00%
- Beta ?
- 0.53
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 62
- Value
- 59
- Quality
- 28
- Growth
- 100
Stocklytics score rationale: value 59, quality 28, growth 100.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 422000 | 10455000 | 0 | 10386000 | 353000 | 235000 | 190000 |
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is…
Fair value
ATYR fair value $5.55. Price $0.13. Price is 98% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 28.30K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 98.09M. Net debt 1.29M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.11 | — | 2.50M |
| 2026-08-07 | -0.11 | -0.12 | 189.56M | — |
| 2026-05-15 | -0.11 | -0.16 | — | — |
| 2026-03-05 | -0.14 | -0.18 | — | 40.00K |
| 2025-11-06 | -0.26 | -0.20 | 190.00K | 20.00K |
| 2025-08-07 | -0.22 | -0.18 | — | — |
| 2025-05-07 | -0.17 | -0.19 | — | — |
| 2025-03-13 | -0.18 | -0.23 | — | 15.56K |
| 2024-11-07 | -0.23 | -0.22 | — | 21.67K |
| 2024-08-13 | -0.23 | -0.22 | — | 20.00K |
| 2024-05-02 | -0.23 | -0.24 | 235.00K | 36.67K |
| 2024-03-14 | -0.25 | -0.24 | — | 3.42M |
| 2023-09-30 | -0.20 | -0.23 | 353.00K | 1.50M |
| 2023-06-30 | -0.22 | -0.28 | — | 611.67K |
| 2023-03-31 | -0.29 | -0.35 | — | 2.36M |
| 2023-03-09 | -0.26 | -0.48 | 10.39M | 357.14K |
| 2022-11-10 | -0.46 | -0.46 | — | 400.00K |
| 2022-08-15 | -0.44 | -0.38 | — | 2.50M |
| 2019-12-31 | -1.54 | — | 144.00K | — |
| 2019-09-30 | -1.47 | — | 184.00K | — |
| 2019-06-30 | -1.80 | — | 94.00K | — |
| 2019-03-31 | -2.54 | — | — | — |
| 2018-12-31 | -2.92 | — | — | — |
| 2018-09-30 | -3.33 | — | — | — |
| 2018-06-30 | -4.88 | — | — | — |
| 2018-03-31 | -5.01 | — | — | — |
| 2017-12-31 | -5.40 | — | — | — |
| 2017-09-30 | -6.07 | — | — | — |
| 2017-06-30 | -7.14 | — | — | — |
| 2017-03-31 | -7.91 | — | — | — |
| 2016-12-31 | -7.42 | — | — | — |
| 2016-09-30 | -8.16 | — | — | — |
| 2016-06-30 | -9.10 | — | — | — |
| 2016-03-31 | -9.53 | — | — | — |
| 2015-12-31 | -9.78 | — | — | — |
| 2015-09-30 | -6.73 | — | — | — |
| 2015-06-30 | -10.41 | — | — | — |
| 2015-03-31 | -5.63 | — | — | — |
| 2014-12-31 | -102.16 | — | — | — |
| 2014-09-30 | -9.22 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Yaras Brandon | Buy | 410.00K | $0.30 | 123.00K |
| 2026-10-01 | Yaras Brandon | Other | 70.00K | $3.48 | 243.60K |
| 2026-10-01 | Yaras Brandon | Other | 28.45K | $2.19 | 62.45K |
| 2026-10-01 | Yaras Brandon | Other | 55.00K | $1.50 | 82.50K |
| 2026-10-01 | Yaras Brandon | Other | 84.14K | $3.74 | 314.69K |
| 2026-10-01 | Yaras Brandon | Other | 88.00K | — | — |
| 2026-05-27 | SCHIMMEL PAUL | Buy | 100.00K | $0.50 | 49.63K |
| 2026-05-11 | Coughlin Timothy | Buy | 50.00K | $0.95 | 47.50K |
| 2026-05-11 | BENEVICH ERIC | Buy | 50.00K | $0.95 | 47.50K |
| 2026-05-11 | Gross Jane A | Buy | 50.00K | $0.95 | 47.50K |
| 2026-05-11 | Lucas Svetlana | Buy | 50.00K | $0.95 | 47.50K |
| 2026-05-11 | Zaknoen Sara | Buy | 50.00K | $0.95 | 47.50K |
| 2026-05-11 | SCHIMMEL PAUL | Buy | 50.00K | $0.95 | 47.50K |
| 2026-02-04 | Shukla Sanjay | Sell | 3.75K | $0.98 | 3.66K |
| 2026-02-04 | Broadfoot Jill Marie | Sell | 1.56K | $0.98 | 1.52K |
| 2026-02-04 | DENYES NANCY | Sell | 1.12K | $0.98 | 1.09K |
| 2026-02-03 | Shukla Sanjay | Buy | 10.38K | — | — |
| 2026-02-03 | Shukla Sanjay | Sell | 10.38K | — | — |
| 2026-02-03 | Broadfoot Jill Marie | Buy | 3.75K | — | — |
| 2026-02-03 | Broadfoot Jill Marie | Sell | 3.75K | — | — |
| 2026-02-03 | DENYES NANCY | Buy | 2.69K | — | — |
| 2026-02-03 | DENYES NANCY | Sell | 2.69K | — | — |
| 2026-01-09 | Shukla Sanjay | Buy | 1.50M | $0.71 | 1.07M |
| 2026-01-09 | Broadfoot Jill Marie | Buy | 412.50K | $0.71 | 293.99K |
| 2026-01-09 | DENYES NANCY | Buy | 412.50K | $0.71 | 293.99K |
| 2025-10-09 | SCHIMMEL PAUL | Buy | 318.00K | $0.94 | 299.36K |
| 2025-10-08 | SCHIMMEL PAUL | Buy | 682.00K | $0.90 | 612.44K |
| 2025-05-01 | Zaknoen Sara | Buy | 50.00K | $3.34 | 167.00K |
| 2025-05-01 | SCHIMMEL PAUL | Buy | 50.00K | $3.34 | 167.00K |
| 2025-05-01 | Lucas Svetlana | Buy | 50.00K | $3.34 | 167.00K |
| 2025-05-01 | Gross Jane A | Buy | 50.00K | $3.34 | 167.00K |
| 2025-05-01 | BENEVICH ERIC | Buy | 50.00K | $3.34 | 167.00K |
| 2025-05-01 | COUGHLIN TIMOTHY | Buy | 50.00K | $3.34 | 167.00K |
| 2025-03-17 | Gross Jane A | Buy | 3.75K | $4.00 | 15.00K |
| 2025-02-04 | Broadfoot Jill Marie | Sell | 1.25K | $3.78 | 4.74K |
| 2025-02-04 | DENYES NANCY | Sell | 899 | $3.78 | 3.40K |
| 2025-02-03 | Shukla Sanjay | Buy | 10.38K | — | — |
| 2025-02-03 | Shukla Sanjay | Sell | 10.38K | — | — |
| 2025-02-03 | Broadfoot Jill Marie | Buy | 3.75K | — | — |
| 2025-02-03 | Broadfoot Jill Marie | Sell | 3.75K | — | — |
| 2025-02-03 | DENYES NANCY | Buy | 2.69K | — | — |
| 2025-02-03 | DENYES NANCY | Sell | 2.69K | — | — |
| 2025-01-08 | Shukla Sanjay | Buy | 1.00M | $3.74 | 3.74M |
| 2025-01-08 | Broadfoot Jill Marie | Buy | 275.00K | $3.74 | 1.03M |
| 2025-01-08 | DENYES NANCY | Buy | 275.00K | $3.74 | 1.03M |
| 2024-12-10 | BENEVICH ERIC | Buy | 100.00K | $3.29 | 329.00K |
| 2024-12-10 | BENEVICH ERIC | Other | 0 | — | — |
| 2024-07-24 | SCHIMMEL PAUL | Buy | 52.30K | $1.93 | 101.04K |
| 2024-07-23 | SCHIMMEL PAUL | Buy | 6.65K | $1.82 | 12.07K |
| 2024-07-22 | SCHIMMEL PAUL | Buy | 41.05K | $1.74 | 71.50K |
| 2024-06-05 | DENYES NANCY | Buy | 5.00K | $1.86 | 9.28K |
| 2024-05-31 | Broadfoot Jill Marie | Buy | 5.00K | $1.79 | 8.95K |
| 2024-05-31 | Shukla Sanjay | Buy | 20.00K | $1.81 | 36.14K |
| 2024-05-30 | COUGHLIN TIMOTHY | Buy | 50.00K | $1.75 | 87.50K |
| 2024-05-22 | CLARKE JOHN K | Buy | 24.00K | $1.86 | 44.64K |
| 2024-05-22 | Gross Jane A | Buy | 24.00K | $1.86 | 44.64K |
| 2024-05-22 | Lucas Svetlana | Buy | 24.00K | $1.86 | 44.64K |
| 2024-05-22 | SCHIMMEL PAUL | Buy | 24.00K | $1.86 | 44.64K |
| 2024-05-22 | Zaknoen Sara | Buy | 24.00K | $1.86 | 44.64K |
| 2024-05-22 | COUGHLIN TIMOTHY | Buy | 24.00K | $1.86 | 44.64K |
| 2024-02-06 | Broadfoot Jill Marie | Sell | 1.59K | $1.69 | 2.69K |
| 2024-02-05 | Shukla Sanjay | Buy | 10.38K | — | — |
| 2024-02-05 | Shukla Sanjay | Sell | 10.38K | — | — |
| 2024-02-05 | Broadfoot Jill Marie | Buy | 3.75K | — | — |
| 2024-02-05 | Broadfoot Jill Marie | Sell | 3.75K | — | — |
| 2024-02-05 | DENYES NANCY | Buy | 2.69K | — | — |
| 2024-02-05 | DENYES NANCY | Sell | 2.69K | — | — |
| 2024-01-05 | Shukla Sanjay | Buy | 600.00K | $1.50 | 900.00K |
| 2024-01-05 | Broadfoot Jill Marie | Buy | 150.00K | $1.50 | 225.00K |
| 2024-01-05 | DENYES NANCY | Buy | 150.00K | $1.50 | 225.00K |
| 2023-12-12 | Shukla Sanjay | Buy | 12.00K | $1.18 | 14.14K |
| 2023-12-11 | Shukla Sanjay | Buy | 3.00K | $1.17 | 3.51K |
| 2023-11-13 | Shukla Sanjay | Buy | 13.58K | $1.11 | 15.09K |
| 2023-11-10 | Shukla Sanjay | Buy | 1.42K | $1.14 | 1.62K |
| 2023-07-28 | Shukla Sanjay | Buy | 15.00K | $2.01 | 30.22K |
| 2023-05-17 | Zaknoen Sara | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-17 | SCHIMMEL PAUL | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-17 | Lucas Svetlana | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-17 | Gross Jane A | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-17 | COUGHLIN TIMOTHY | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-17 | COUGHLIN TIMOTHY | Buy | 6.00K | — | — |
| 2023-05-17 | COUGHLIN TIMOTHY | Sell | 6.00K | — | — |
| 2023-05-17 | CLARKE JOHN K | Buy | 12.00K | $2.52 | 30.24K |
| 2023-05-10 | SCHIMMEL PAUL | Buy | 200.00K | $2.25 | 450.00K |
| 2023-04-26 | Zaknoen Sara | Buy | 6.00K | — | — |
| 2023-04-26 | Zaknoen Sara | Sell | 6.00K | — | — |
| 2023-04-26 | CLARKE JOHN K | Buy | 6.00K | — | — |
| 2023-04-26 | CLARKE JOHN K | Sell | 6.00K | — | — |
| 2023-04-26 | SCHIMMEL PAUL | Buy | 6.00K | — | — |
| 2023-04-26 | SCHIMMEL PAUL | Sell | 6.00K | — | — |
| 2023-04-26 | Lucas Svetlana | Buy | 6.00K | — | — |
| 2023-04-26 | Lucas Svetlana | Sell | 6.00K | — | — |
| 2023-04-26 | Gross Jane A | Buy | 6.00K | — | — |
| 2023-04-26 | Gross Jane A | Sell | 6.00K | — | — |
| 2023-04-26 | COUGHLIN TIMOTHY | Buy | 6.00K | — | — |
| 2023-04-26 | COUGHLIN TIMOTHY | Sell | 6.00K | — | — |
| 2023-02-16 | Shukla Sanjay | Buy | 336.10K | $2.19 | 737.73K |
| 2023-02-16 | Broadfoot Jill Marie | Buy | 84.02K | $2.19 | 184.43K |
| 2023-02-16 | DENYES NANCY | Buy | 84.02K | $2.19 | 184.43K |
| 2023-02-06 | Broadfoot Jill Marie | Sell | 1.57K | $2.36 | 3.70K |
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Earnings and financials
aTyr Pharma, Inc. (ATYR) trades at $0.13, with a market cap of $12.46M and a trailing P/E of -0.25. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 422000 | 10455000 | 0 | 10386000 | 353000 | 235000 | 190000 |
Insights · Dividends · Forecast · Financials · Learn